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Monitoring the marketing of infant formula feeds
Manufacturers of breast milk substitutes violate the WHO code—again
Breast feeding is one of the most cost effectiveinterventions to improve health and preventillness in early childhood. Protection of breast
feeding from commercial exploitation should be among
the highest priorities for the international community,
yet violations of the World Health Organization’s code
of marketing of breast milk substitutes have been seen
regularly, despite companies’ expressed intentions to
conform.1–3 The study by Aguayo et al in west Africa in
this issue (p 127) provides further evidence that many
manufacturers fly in the face of the code by providing
free samples, giving donations to health workers, and
contravening standards for labelling.4
How reliable is the methodology of the study? The
selection of health centres to be monitored was either
random or complete. The number of mothers
interviewed was modest: 105 compared with 1582 in
the 1998 study,2 and, surprisingly, more health workers
than mothers were interviewed. None the less, many of
the figures are comparable to the study by Taylor,
although the frequency of violations is rather lower in
this research.
It is particularly disturbing that in Togo, 85% of
health workers had never heard of the WHO code and
none had participated in training, whereas in Burkina
Faso, 40% worked in a “baby friendly” facility but only
17% had participated in training. This indicates a
failure of the training and accreditation systems in
these facilities.
Three essential issues arise from this study. Firstly,
how should we monitor compliance of the code effec›
tively to reduce the continuing violations? As Carol
Bellamy, executive director of Unicef, said in welcom›
ing the report that led to Taylor’s paper: “The question
now becomes: how do we proceed when all the
evidence suggests that, despite the protestations of
good faith by the breast milk substitute manufacturers,
many continue to view the international code as a cov›
enant more to be honoured in the breach than in the
substance?”5 Currently three international models of
monitoring exist: the WHO Common Review and
Evaluation Framework (WHO/NUT/96.2), the Inter›
national Baby Food Action Network (IBFAN) Monitor›
ing Forms Manual (email ibfanpg@tm.net.my), and the
Interagency Group on Breastfeeding Monitoring
(IGBM) protocol currently in draft (www.scfuk.org.uk/
development/links/IGBM.htm). The third has the
advantage of assessing compliance with both the inter›
national code and national legislation and describes
clearly the sampling method used. Endorsement of a
protocol such as this by the international community
would advance the enforcement of the code by all
member states as well as individual manufacturers.
Secondly, how should we train health workers
about the protection and support of breast feeding?
The potential benefits of the Unicef baby friendly
initiative of accrediting health facilities are consider›
able and now evidence based.6 There are also
indications that the initiative has led to an arrest in the
worldwide decline in breast feeding.7 Training of health
workers is an essential prerequisite to reducing the
harmful effects of health services, but pretraining
should be carried out systematically and periodically so
that new workers are included, and there should be an
emphasis on the development of advocacy skills.8 9
Thirdly, how should we combine support for breast
feeding with a recognition of the risk of maternally
transmitted HIV infection. It should be made
absolutely clear that in most poor countries afflicted by
AIDS the risk of bottle feeding is higher than the risk of
mother to infant transmission of HIV infection. This
fact needs to be continually reiterated to decision mak›
ers as otherwise manufacturers of breast milk
substitutes will capitalise on HIV infection as a reason
for promoting free samples of their formula.10 It is
extraordinary that the Wall Street Journal painted the
baby food manufacturers as heroes poised to save Afri›
can children from certain death because of their offer
to donate free formula to HIV infected mothers.11 The
WHO recommends avoidance of breast feeding by
HIV infected mothers only if replacement feeding is
feasible, safe, sustainable, and affordable—otherwise
exclusive breast feeding is recommended during the
first six months of life.12 Non›infected women must be
given access to credible information, quality care, and
support, in order to empower them to make informed
decisions regarding feeding of their infant.13
Governments should accept promotion and pro›
tection of breast feeding as a critical area for improving
child health. The WHO code is central to ensuring this
protection, but a better way of monitoring and enforc›
ing its application in both industrialised and low
income countries must be identified.
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Preventing skin cancer
Messages should emphasise the need to cover up and stay out of the sun
Health promotion strategies to prevent deathsfrom skin cancer, particularly melanoma, havetwo components: advice on early recognition
and advice on prevention. The population is perhaps
heeding advice on early recognition. Five year survival
from melanoma in England and Wales is improving,
particularly in female patients,1 probably because the
cancer is diagnosed at an earlier stage owing to
increased public awareness. But the incidence of
melanoma is increasing in the United Kingdom and the
United States;1 2 in the United Kingdom it has doubled
over the past 20 years.1 This contrasts with a falling inci›
dence in Australia,3 but it is not clear whether this differ›
ence is attributable to the Australian prevention
campaign having been active for longer or whether pre›
vention messages are less effective in the United
Kingdom. By 1996, attitudes among Australian students
had already shifted positively towards avoiding exposure
to the sun and away from the use of sunscreen and
desire for a tan.4 In contrast, a study of 80 students in the
United Kingdom published in 2000 found that most
emphasised positive benefits of sun exposure, enjoyed
sunbathing, protected themselves inadequately, and did
not intend to change this behaviour.5
Experts believe that 90% of non›melanoma skin
cancers and two thirds of melanomas may be
attributed to excessive exposure to the sun.2 Although
no direct evidence shows that sunbeds cause skin can›
cer, they are a source of intense exposure to ultraviolet
radiation, and according to a recent report from the
National Radiological Protection Board therefore rep›
resent a potential health risk.6 Campaigns to prevent
skin cancer have incorporated numerous messages
including the need to avoid sunburn and generally
reduce exposure to ultraviolet radiation by staying out
of the midday sun, wearing protective clothing, seeking
shade, and applying sunscreen. In recent years the
advice on sunscreen has included recommendations
for the use of broadband preparations with a higher
sun protection factor. Early health promotional
material did not give greater emphasis to any one
means of protection over another. Little discussion has
taken place of the fact that skin tanned by ultraviolet
radiation is damaged skin or of the potential risks of
using sunbeds.
A tanned appearance remains fashionable, and,
although there has been a marked increase in sales of
self tanning lotions in western Europe and the United
States (market data, Euromonitor 2002), no evidence
has shown that this is replacing exposure to ultraviolet
radiation. Despite having a good understanding of the
relation between overexposure to the sun and skin
cancer, 81% of Americans still think they look good
after being in the sun.7 Risk taking behaviour with
respect to exposure to the sun continues.5 8 The
availability of sunbeds on high streets in the United
Kingdom seems to be increasing, but we could find no
sources of data on trends in access to and use of com›
mercial sunbeds to confirm this. The licensing by local
authorities of commercial premises in the United
Kingdom offering cosmetic sunbed tanning depends
on the application of bylaws and is currently
discretionary. Few local authorities choose to license
and data currently collected cannot be used to monitor
trends. The only data we could find to support the
hypothesis that the use of sunbeds is increasing was
from one American tanning firm, whose turnover rose
from $2.8m (£1.8m; &2.8m) in 1990 to $15m in 2002.9
In the absence of any other data these figures could
alternatively represent a changing market share.
The equal emphasis placed on the use of sunscreen
versus avoiding exposure to the sun or wearing protec›
tive clothing in early prevention campaigns in the
United Kingdom may have led to confusion. Surveys
carried out in the United Kingdom have found that
sunscreen is regarded as the most important sun pro›
tection measure.10 It is still unclear, however, whether
sunscreens effectively protect against skin cancer, and
concern has been raised that they may directly or indi›
rectly increase the risk of disease, primarily because of
poor application and increased exposure to the sun.6
Sunscreens with a high sun protection factor do
not always prevent sunburn, although they should if
applied according to the manufacturer’s directions.10
The thickness of application has been shown to be less
than half that officially tested and key exposed sites
(neck, temples, and ears) are often missed completely.11
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